Medical Device | April 28, 2026
Stryker launches Trident II Hip System in India
New acetabular system enhances precision, stability and robotic compatibility in total hip arthroplasty
New acetabular system enhances precision, stability and robotic compatibility in total hip arthroplasty
Rs. 40 cr buyback, 200% dividend announced
New model focuses on continuity of care, combining therapy, routine and social engagement to support long-term recovery
The agreements aim to strengthen medicine quality, patient safety and pharmaceutical research in India
Multi-stakeholder initiative highlights inclusive sports pathways, honours neurodivergent athletes, and calls for systemic reforms
The Pharmaceuticals portfolio and pipeline are more promising than perhaps ever before
The acquisition brings three established small-molecule drug substance facilities into Siegfried’s global network
Our company is prioritising deeper collaborations with CDMOs and biosimilar companies as part of its strategy to expand its footprint across India, Middle East, and Africa region
Extending production capabilities to the Americas helps reduce labor costs and inventory complexity for nutraceuticals and other industries while maintaining superior moisture control
The study evaluated oral semaglutide in young patients with type 2 diabetes and found it delivered a superior reduction in HbA1c
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
